IPO Boutique Research, Color & More Information for Subscribers
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter Invitation Homes (NYSE: INVH) — Invitation Homes priced 77mm shares at $20.00 and will debut on Wednesday (2/1). The initial range was $18-$21. This would raise $1.54bn marking the largest cash raise by an IPO since October 2015. Press Release Laureate Education (Nasdaq: LAUR) — Laureate Education upsized its offering and[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Synergy Pharmaceuticals, Inc. Symbol: SGYP Price: Last trade $7.07 Description: Re-offer range $6.60-$6.85 Trade Date: 2/1 Shares: 17.7 million Underwriter(s)Cantor Fitzgerald,[…]
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter The IPO market came to life after the MLK day holiday as seven deals priced raising a total of $2.1bn. Two deals priced above range and 1 priced below range. The average gain at first trade was 6.3% above the offering price. The first technology deal of 2017 was[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Rigel Pharmaceuticals Symbol: RIGL Price: Last trade $2.08 Description: Re-offer $2.00 Trade Date: 1/31 Shares: 17.5 million Underwriter(s)Jefferies, Piper Jaffray, BMO[…]
The most high-profile IPO of 2017, Snap Inc., continues to leak information that an official IPO filing is imminent. The latest ‘drip’ comes from Recode’s Kara Swisher who reported late Friday night that Snap will officially file sometime later this week and possibly seek up to a $25bn valuation. Reuters is reporting that SnapChat will[…]
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is[…]
It was much to do about nothing. Thanks AppDynamics. Capital market bankers, brokers marketing the deal to their clients and those high within the industry were all shocked and selfishly-disappointed that a hot-deal would not come to market. The deal was multiple-times oversubscribed, already had an increased range (bumped from $10-$12 to $12-$14) and was[…]
NEW FILINGS None to Report TERMS ADDED Company: Ramaco Resources Symbol: METC Price: $12.00-$15.00 Description: They are a developer of high-quality, low-cost metallurgical coal in central and southern West Virginia, southwestern Virginia, and southwestern Pennsylvania. Trade Date: 2/3 Shares: 6.5 million Underwriter(s): Credit Suisse, Jefferies, BMO Capital Markets Co Manager(s): Clarkson’s Platou Securities, Seaport Global[…]
Endra Life Sciences (Nasdaq: NDRA) — The offering is led by Dougherty & Company, Dawson James and is looking to price 2m shares at $5.00-$5.50. According to the Motif Investing site, this deal is now looking to trade on 2/3. Jagged Peak Energy (NYSE: JAG) — Jagged Peak Energy downsized and priced $1.00 below the range.[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Workhorse Symbol: WKHS Price: Last trade $3.47 Description: Re-offer $3.00 Trade Date: 1/27 Shares: 4.3 million Underwriter(s)Oppenheimer & Co., Cowen &[…]
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter The first IPO blow-up of 2017 is in the books. ObsEva Inc. (Nasdaq: OBSV) priced 6.45 million shares at the mid-point of the $14- $16 range through three underwriters: Credit Suisse, Jefferies and Leerink Partners. ObsEva raised $96.75m in the IPO process and even rang the bell at the Nasdaq[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Entellus Medical, Inc. Symbol: ENTL Price: Last trade $19.39 Description: Re-offer range $17.00-$18.00 Trade Date: 1/26 Shares: 3.1 million Underwriter(s)BofA Merrill[…]
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter Two healthcare stocks are set to price on Wednesday (1/25) night for Thursday (1/26) trading. AnaptysBio (Nasdaq: ANAB) up-sized its offering and priced at the mid-point of the range. $ANAB priced 5m shares at $15.00. The initial size and range according to the latest S-1/A filing was for 4m[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Horizon Global Corporation Symbol: HZN Price: Last trade $20.89 Trade Date: 1/27 Shares: 3.5 million Underwriter(s)Wells Fargo, J.P. Morgan, BofA Merrill[…]
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is[…]
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter You think there are a lot of Snap Inc. stories now? …a hoard of headlines are yet to come. For IPO investors, the wait will continue until an official S-1/A is filed with terms. However, it is highly positive to see the amount of stories trickling out about the[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Pinnacle Financial Partners, Inc. Symbol: PNFP Price: Last trade $64.25 Description: Re-offer range $61.25-$63.25 Trade Date: 1/24 Shares: 2.7 million Underwriter(s)J.P.[…]
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter Invitation Homes was one of three companies who set terms for an IPO on Monday morning bringing the total deal count for the week of January 30 to a total of five. The Blackstone Group owned ‘INVH’ is looking to sell a grand total of 77 million shares for[…]
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter Market sentiment and political rhetoric surrounding the healthcare sector of the market is beyond bad. Democrats, Republicans, rich and poor have collectively made drug companies their own personal punching bags. Donald Trump about drug companies said, and this is a direct quote, “(They) are getting away with murder.” These comments,[…]
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is[…]
